160 related articles for article (PubMed ID: 25231404)
41. Overexpression of calreticulin contributes to the development and progression of pancreatic cancer.
Sheng W; Chen C; Dong M; Zhou J; Liu Q; Dong Q; Li F
J Cell Physiol; 2014 Jul; 229(7):887-97. PubMed ID: 24264800
[TBL] [Abstract][Full Text] [Related]
42. ING5 Inhibits Migration and Invasion of Esophageal Cancer Cells by Downregulating the IL-6/CXCL12 Signaling Pathway.
Wang Y; Tan J; Li J; Chen H; Wang W
Technol Cancer Res Treat; 2021; 20():15330338211039940. PubMed ID: 34520285
[TBL] [Abstract][Full Text] [Related]
43. NRP1 knockdown promotes the migration and invasion of human neuroblastoma-derived SK‑N‑AS cells via the activation of β1 integrin expression.
Ishizuka Y; Koshinaga T; Hirano T; Nagasaki-Maeoka E; Watanabe Y; Hoshi R; Yoshizawa S; Sugito K; Kawashima H; Uekusa S; Fukuda N; Soma M; Fujiwara K
Int J Oncol; 2018 Jul; 53(1):159-166. PubMed ID: 29750423
[TBL] [Abstract][Full Text] [Related]
44. LMP1 Up-regulates Calreticulin to Induce Epithelial-mesenchymal Transition via TGF-β/Smad3/NRP1 Pathway in Nasopharyngeal Carcinoma Cells.
Ye D; Zhu J; Zhao Q; Ma W; Xiao Y; Xu G; Zhang Z
J Cancer; 2020; 11(5):1257-1269. PubMed ID: 31956372
[No Abstract] [Full Text] [Related]
45. A Novel Physiological Glycosaminoglycan-Deficient Splice Variant of Neuropilin-1 Is Anti-Tumorigenic In Vitro and In Vivo.
Hendricks C; Dubail J; Brohée L; Delforge Y; Colige A; Deroanne C
PLoS One; 2016; 11(10):e0165153. PubMed ID: 27798666
[TBL] [Abstract][Full Text] [Related]
46. No functional and transductional significance of specific neuropilin 1 siRNA inhibition in colon carcinoma cell lines lacking VEGF receptor 2.
Quante M; Raskopf E; Stahl S; Vogt A; Sauerbruch T; Schmitz V
Oncol Rep; 2009 May; 21(5):1161-8. PubMed ID: 19360289
[TBL] [Abstract][Full Text] [Related]
47. Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma.
Dumond A; Brachet E; Durivault J; Vial V; Puszko AK; Lepelletier Y; Montemagno C; Pagnuzzi-Boncompagni M; Hermine O; Garbay C; Lagarde N; Montes M; Demange L; Grépin R; Pagès G
J Exp Clin Cancer Res; 2021 Jan; 40(1):33. PubMed ID: 33461580
[TBL] [Abstract][Full Text] [Related]
48. Combination of NRP1-mediated iRGD with 5-fluorouracil suppresses proliferation, migration and invasion of gastric cancer cells.
Zhang L; Xing Y; Gao Q; Sun X; Zhang D; Cao G
Biomed Pharmacother; 2017 Sep; 93():1136-1143. PubMed ID: 28738522
[TBL] [Abstract][Full Text] [Related]
49. Neuropilin1 silencing impairs the proliferation and migration of cells in pancreatic cancer.
He LH; He YL; Zuo WH; Kang Y; Xue H; Wang LY; Zhang YL; Meng Y
J Clin Lab Anal; 2020 Sep; 34(9):e23394. PubMed ID: 32472711
[TBL] [Abstract][Full Text] [Related]
50. F806 Suppresses the Invasion and Metastasis of Esophageal Squamous Cell Carcinoma via Downregulating F-Actin Assembly-Related Rho Family Proteins.
Xie L; Li LY; Zheng D; Xie YM; Xu XE; Tao LH; Liao LD; Xie YH; Cheng YW; Xu LY; Li EM
Biomed Res Int; 2018; 2018():2049313. PubMed ID: 30327774
[TBL] [Abstract][Full Text] [Related]
51. SOX30 is a key regulator of desmosomal gene suppressing tumor growth and metastasis in lung adenocarcinoma.
Hao X; Han F; Ma B; Zhang N; Chen H; Jiang X; Yin L; Liu W; Ao L; Cao J; Liu J
J Exp Clin Cancer Res; 2018 May; 37(1):111. PubMed ID: 29855376
[TBL] [Abstract][Full Text] [Related]
52. Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality.
Tse BWC; Volpert M; Ratther E; Stylianou N; Nouri M; McGowan K; Lehman ML; McPherson SJ; Roshan-Moniri M; Butler MS; Caradec J; Gregory-Evans CY; McGovern J; Das R; Takhar M; Erho N; Alshalafa M; Davicioni E; Schaeffer EM; Jenkins RB; Ross AE; Karnes RJ; Den RB; Fazli L; Gregory PA; Gleave ME; Williams ED; Rennie PS; Buttyan R; Gunter JH; Selth LA; Russell PJ; Nelson CC; Hollier BG
Oncogene; 2017 Jun; 36(24):3417-3427. PubMed ID: 28092670
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of STAT5a by Naa10p contributes to decreased breast cancer metastasis.
Zeng Y; Min L; Han Y; Meng L; Liu C; Xie Y; Dong B; Wang L; Jiang B; Xu H; Zhuang Q; Zhao C; Qu L; Shou C
Carcinogenesis; 2014 Oct; 35(10):2244-53. PubMed ID: 24925029
[TBL] [Abstract][Full Text] [Related]
54. A novel role for tissue factor pathway inhibitor-2 in the therapy of human esophageal carcinoma.
Ran Y; Pan J; Hu H; Zhou Z; Sun L; Peng L; Yu L; Sun L; Liu J; Yang Z
Hum Gene Ther; 2009 Jan; 20(1):41-9. PubMed ID: 20377370
[TBL] [Abstract][Full Text] [Related]
55. N-glycosylation-defective splice variants of neuropilin-1 promote metastasis by activating endosomal signals.
Huang X; Ye Q; Chen M; Li A; Mi W; Fang Y; Zaytseva YY; O'Connor KL; Vander Kooi CW; Liu S; She QB
Nat Commun; 2019 Aug; 10(1):3708. PubMed ID: 31420553
[TBL] [Abstract][Full Text] [Related]
56. NRP1-positive lung cancer cells possess tumor-initiating properties.
Jimenez-Hernandez LE; Vazquez-Santillan K; Castro-Oropeza R; Martinez-Ruiz G; Muñoz-Galindo L; Gonzalez-Torres C; Cortes-Gonzalez CC; Victoria-Acosta G; Melendez-Zajgla J; Maldonado V
Oncol Rep; 2018 Jan; 39(1):349-357. PubMed ID: 29138851
[TBL] [Abstract][Full Text] [Related]
57. STAT5A-mediated NOX5-L expression promotes the proliferation and metastasis of breast cancer cells.
Dho SH; Kim JY; Lee KP; Kwon ES; Lim JC; Kim CJ; Jeong D; Kwon KS
Exp Cell Res; 2017 Feb; 351(1):51-58. PubMed ID: 28034671
[TBL] [Abstract][Full Text] [Related]
58. Immunohistochemical study on neuropilin 1 (NRP1) immunoexpression in oral squamous cell carcinoma.
Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Danilewicz M
Folia Histochem Cytobiol; 2018; 1(2):98-105. PubMed ID: 29873058
[TBL] [Abstract][Full Text] [Related]
59. Increased expression of neuropilin 1 in melanoma progression and its prognostic significance in patients with melanoma.
Lu J; Cheng Y; Zhang G; Tang Y; Dong Z; McElwee KJ; Li G
Mol Med Rep; 2015 Aug; 12(2):2668-76. PubMed ID: 25954957
[TBL] [Abstract][Full Text] [Related]
60. NRP1 promotes cell migration and invasion and serves as a therapeutic target in nasopharyngeal carcinoma.
Huang Z; Cheng C; Xiong H; Wang Y; Chen KK; Yang J; Xiao B; Zhang R; Li S; Sang Y
Int J Clin Exp Pathol; 2018; 11(5):2460-2469. PubMed ID: 31938358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
